Clinical Trials Directory

Trials / Completed

CompletedNCT05979467

The Relationship Between Serum Endocan and ADMA Levels and Penile Doppler Ultrasonography in Erectile Dysfunction

The Relationship Between Serum Endocan and ADMA Levels and Penile Doppler Ultrasonography Findings in Patients With Vasculogenic Erectile Dysfunction

Status
Completed
Phase
Study type
Observational
Enrollment
73 (actual)
Sponsor
Ankara Etlik City Hospital · Other Government
Sex
Male
Age
50 Years – 70 Years
Healthy volunteers

Summary

The gold standard diagnosis in patients admitted to the hospital with the complaint of erectile dysfunction is penile doppler ultrasonography. This procedure is an invasive procedure and can cause various complications. Therefore, in this study, we aimed to support and define the diagnosis of erectile dysfunction with some biomarkers that can be measured in blood samples. At this point, we performed penile doppler ultrasonography, which is the gold standard test, for all patients who applied with the complaint of erectile dysfunction, and compared the results of penile doppler and serum biomarkers in the patients.

Conditions

Timeline

Start date
2017-04-17
Primary completion
2020-01-20
Completion
2020-06-12
First posted
2023-08-07
Last updated
2023-08-07

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT05979467. Inclusion in this directory is not an endorsement.

The Relationship Between Serum Endocan and ADMA Levels and Penile Doppler Ultrasonography in Erectile Dysfunction (NCT05979467) · Clinical Trials Directory